About Molcure
Molcure is a company based in Tokyo (Japan) founded in 2013 by Yutaro Kyono and Ryu Ogawa.. Molcure has raised $11.73 million across 5 funding rounds from investors including Dai-Ichi Life, Nippon ChemiPhar and JAFCO Group. Molcure operates in a competitive market with competitors including Biological Dynamics, Depixus, Genomics, Seven Bridges Genomics and Oxford Immunotec, among others.
- Headquarter Tokyo, Japan
- Founders Yutaro Kyono, Ryu Ogawa
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.73 M (USD)
in 5 rounds
-
Latest Funding Round
$7.2 M (USD), Series C
Aug 18, 2021
-
Investors
Dai-Ichi Life
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Molcure
Molcure has successfully raised a total of $11.73M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $7.2 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $7.2M
-
First Round
First Round
(31 Jul 2013)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series C - Molcure | Valuation | JAFCO Group | |
| Dec, 2018 | Amount | Series B - Molcure | Valuation | Dai-Ichi Life , GMO Venture Partners |
|
| Jun, 2016 | Amount | Grant - Molcure | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molcure
Molcure has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Dai-Ichi Life, Nippon ChemiPhar and JAFCO Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital support is provided to seed and early-stage startups.
|
Founded Year | Domain | Location | |
|
Private equity investment firm backed by Japan Post Group
|
Founded Year | Domain | Location | |
|
Early-stage tech ventures in the US and Asia are funded.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molcure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molcure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molcure Comparisons
Competitors of Molcure
Molcure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Depixus, Genomics, Seven Bridges Genomics and Oxford Immunotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Molcure
Frequently Asked Questions about Molcure
When was Molcure founded?
Molcure was founded in 2013.
Where is Molcure located?
Molcure is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Who is the current CEO of Molcure?
Ryu Ogawa is the current CEO of Molcure. They have also founded this company.
Is Molcure a funded company?
Molcure is a funded company, having raised a total of $11.73M across 5 funding rounds to date.
What does Molcure do?
The company was founded in 2013 in Tokyo, Japan, within the biotechnology sector. An AI-driven platform is offered for drug discovery and molecular design. Next-generation sequencing and molecular biology techniques are employed to identify and detect antibody molecules. Core operations center on accelerating therapeutic development through data-driven approaches in the pharmaceutical industry.
Who are the top competitors of Molcure?
Molcure's top competitors include Depixus, Ingenuity Systems and Phoremost.
Who are Molcure's investors?
Molcure has 8 investors. Key investors include Dai-Ichi Life, Nippon ChemiPhar, JAFCO Group, STRIVE, and Japan Post Capital.